Paul Quinlan
2018
In 2018, Paul Quinlan earned a total compensation of $3M as General Counsel at Cymabay Therapeutics.
Compensation breakdown
| Bonus | $157,862 |
|---|---|
| Option Awards | $2,423,370 |
| Salary | $375,863 |
| Other | $4,189 |
| Total | $2,961,284 |
Quinlan received $2.4M in option awards, accounting for 82% of the total pay in 2018.
Quinlan also received $157.9K in bonus, $375.9K in salary and $4.2K in other compensation.
Rankings
In 2018, Paul Quinlan's compensation ranked 3,919th out of 14,244 executives tracked by ExecPay. In other words, Quinlan earned more than 72.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,919 out of 14,244 | 73rd |
Division Manufacturing | 1,446 out of 5,765 | 75th |
Major group Chemicals And Allied Products | 514 out of 2,128 | 76th |
Industry group Drugs | 431 out of 1,817 | 76th |
Industry Pharmaceutical Preparations | 335 out of 1,391 | 76th |
Source: SEC filing on April 26, 2019.
Quinlan's colleagues
We found four more compensation records of executives who worked with Paul Quinlan at Cymabay Therapeutics in 2018.